THE EUROPEAN VOICE
OF PROBIOTICS

IPA EU NEWSROOM


10th PROBIOTICS, PREBIOTICS NEW FOODS, NUTRACEUTICALS AND BOTANICALS for NUTRITION & HUMAN and MICROBIOTA HEALTH

On Monday 9th September 2019, Esbend Laulund, President IPA Europe, opened the session  "THE GLOBAL VOICE OF PROBIOTICS IPA/IPA EUROPE SESSION: How to define a comprehensive approach for the definition of the probiotic category (nutrition relevance and scientific requirements)".

With the help of the experts, we gathered to discuss issues pertaining to the interplay between science, nutrition and regulatory issues for probiotic food and food supplements, and the challenges the probiotics manufactures industry face.

 

Press release


Workshop on “Probiotics and Innovation"

Over 45 representatives, including Member States’ authorities, stakeholders and the European Commission, attended the Workshop on “Probiotics and Innovation” organized in Brussels by the Permanent Representation of Denmark on 6 May.

Read the Press Release

Read the IPA Europe presentation


CLINICAL EVIDENCE AND NOT MICROBIOTA OUTCOMES DRIVE VALUE OF PROBIOTICS

The International Scientific Association of Probiotics and Prebiotics (ISAPP), immediately reacted to the recent papers by Zmora, et al and Suez, et al, with scientific arguments to counter the inaccurate information on probiotics: Hundreds of human trials have demonstrated clinical benefits of probiotics and several evidence-based recommendations have been issued by medical organizations. This irresponsible reporting may lead people who are benefitting from probiotics to stop using them, potentially causing real harm.

Read the ISAPP Response


IPA Europe contends that the recent studies, questioning the health benefits of probiotics, basically confirm the knowledge that we already have on probiotics: namely that probiotic strains are indeed likely to have individual responses.

It is regrettable that, although the authors themselves state that the microbiota is influenced by very many factors and is extremely diverse, their ‘study group” consists of only 8 people, which is too small to be able to reliably evaluate so many parameters or to draw any far-reaching conclusions.

Read the Press Release


‘Brain fogginess’ and D-Lactic Acidosis: Probiotics are not the cause

With regard to a publication alleging a link between 'brain fogginess' and probiotics use, IPA Europe cautions that scientists and clinical researchers – both academic and from industry – must remain diligent in their assessment and reporting of safety concerns that may arise from probiotics use and in science communication to non-expert audiences.

The IPA statement and the ISAPP analysis can be found here


A HUNDRED TRILLION REASONS TO CELEBRATE WORLD MICROBIOME DAY THE 27th OF JUNE

Our microbiota has been suggested to contribute to health in many areas including digestive health and immune health. This new, exciting research area focusses primarily around the gut microbiota. Moreover, several medical and scientific organisations have highly recommended, in their evidence-based guidelines, the use of probiotics to ameliorate gastrointestinal symptoms or diseases in children and adults.
So, Happy Microbiome Day & take care of your microbiome!

Read the Press Release


Resilience as a valid measure of health and the implications for health benefits of specific foods and food ingredients

In a recent ISAPP blog, scientists explored the concept of ‘resilience’ in the context of human physiology, i.e. the ability to remain healthy even when exposed to a stress, or to recover from a stress faster, and concluded that the recent recognition by EFSA that maintenance of homeostasis is a valid measure of health provides an opportunity to apply this concept to specific foods and food ingredients.

Download the Press Release

Download the full text of the ISAPP blog


The global probiotics market is growing rapidly, but Europe is currently lagging behind the American and Asian markets, and may continue to lose market opportunities.

According to Euromonitor data, the global probiotics market is growing rapidly, especially via dairy products and dietary supplements. However, this does not seem to be the case in the European Union (EU), where the interpretation of the European Commission restricts the possibility to inform consumers and stifles both market growth and research and innovation in the probiotic sector.

Download the press release


IPA considers that the development of guidelines and a harmonized framework for probiotics is necessary to ensure and sustain quality probiotic products on a global scale.

IPA activity took place at the 2017 session of the Codex committee on Nutrition and Foods for Special Dietary Uses (CCNFSDU), which was attended by Government representatives, observers and experts from 66 Member States and 41 international organizations, in Berlin from 4 to 8 December 2017.

Download the press release


IPA Europe calls for a harmonized EU approach on Probiotics in order to better inform consumers

In a joint statement – presented at an event titled "Enabling Innovation in Food/Food Supplements" at the European Parliament today – the Probiotic industry stressed the need for meaningful consumer information in the European Union (EU) on Probiotics.?

 

Read the Ipa Europe Press Release

Read the Joint Statement

IPA EU HIGHLIGHTS


10th Congress of Probiotics, Prebiotics, New Foods in Rome, Italy

IPA Europe will patronage the 10th Congress of Probiotics, Prebiotics, New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health, scheduled to take place from 8 to 10 September 2019 in Rome (Italy).

      

On Sunday 8th September, IPA Europe will open the afternoon session with a “Round Table IPA Europe” (14.00-16.00), during which the criteria approach for the use of the term probiotic in food will be presented together with ISAPP. A representative of EFSA will also take part to the Round Table, giving a presentation on EFSA’s remit and role.

On Monday 9th September there will also be a dedicated session on “The global voice of probiotics IPA/IPA Europe: How to define a comprehensive approach for the definition of the probiotic category (nutrition relevance and scientific requirements)”. The session will be opened by IPA Europe President E. Laulund at 11.45 and it will be closed by a panel discussion and conclusions on “How to build a category approach for probiotics”. The session will close at 13.30.


Please find here the Link on the IPA EU programme

Please find here the Link on the Congress


 


9th International Akademie Fresenius Conference "Health Claims and Functional Ingredients"

Health claims and Functional Ingredients: several aspects of the Health Claims Regulations were presented during the Conference “Health Claims and Functional Ingredients” (link), hosted by  Akedemie Fresenius in Mainz (DE) on 4th and 5th June 2019.

The conference’s structure was divided into three different panels: the Legal frame, Application and Authorisation, Nutrition and Functional Ingredients.

IPA Europe was represented by the Executive Director Ms Rosanna Pecere, who gave a presentation on understating probiotics in an European context. During the presentation, Ms Pecere summarised the EU Regulatory Framework on probiotics which penalise the probiotic category, indicating that a correct food information is needed to enable the consumers to make a responsible choice, and concluded presenting  several approaches on how to move forward.


ELECTION OF NEW MEMBER AND ALTERNATE MEMBER OF EFSA’S STAKEHOLDER BUREAU

22 March 2019 – EFSA has just announced the outcome of the election of the new Member and Alternate Member of EFSA’s Stakeholder Bureau:

  • The new member of the Bureau – Ms Maud Perrudin, Deputy Director General, AESGP - Association of the European Self-Medication Industry (41 supporting votes)
  • Alternate Member of the Bureau – Ms Rebeca Fernandez, Director Food Policy, Science and R&D, FoodDrinkEurope (41 supporting votes)

IPA Europe supported the nomination of these two representatives of the Associations registered under the Business and Food Industry Category and we congratulate them on their appointment.

We look forward to continuing on with the constructive discussions that are taking place with EFSA.


MEETING WITH THE EUROPEAN FOOD SAFETY AUTHORITY

On 18 January 2019, IPA Europe met with the European Food Safety Authority (EFSA) in Parma, Italy, for a scientific discussion. This enabled IPA Europe scientific experts to gain a better understanding of the EFSA role and remit, particularly with regard to scientific substantiation of health claims made on food.

A debate also took place regarding the lack of a harmonized EU approach, and the confusion this causes for consumers. It was clear from this exchange that there is an urgent need to ensure recognition of the Probiotics category and to adopt a coherent, harmonized approach within the EU Single Market.

With their mandate limited to providing opinions on health claims, the EFSA cannot be held accountable for the difficult situation of probiotics in Europe. Any changes to the current impasse, can only be initiated by the European Commission. 

IPA Europe will therefore continue dedicating efforts and resources to improving the environment for Probiotics in Europe and is seeking to do so in collaboration with all relevant stakeholders.


PROPOSAL ON "HARMONISED PROBIOTIC GUIDELINES FOR THE USE IN FOODS AND DIETARY SUPPLEMENTS" PRESENTED BY ARGENTINA AT THE 40TH MEETING OF THE CODEX COMMITTEE ON NUTRITION AND FOODS FOR SPECIAL DIETARY USES (CCNFSDU)

The Argentinian delegation introduced the Discussion Paper on “Harmonized Probiotic Guidelines for Use in Foods and Dietary Supplements” on 28 November in Berlin. IPA joined the group of National delegations supporting starting new work.

Read the Statement


SUPPLY SIDE WEST, LAS VEGAS

Last week (6-10 November), Rosanna Pecere (Executive Director IPA Europe) attended Supply Side West (SSW) 2018 – where strategy meets science – in Las Vegas. At this event, leaders in dietary supplement, beverage, functional food, personal care and sports nutrition shared expertise in product development for the global economy. To facilitate navigation, IPA provided the IPA Probiotics Guide for SSW, which included detailed information on the IPA Probiotics Resource Center. Through the IPA workshop on 10 November on “Probiotic Product Development: A Need-To-Know Guide Before Taking That First Step”, a better understanding was gained of strain selection, research insights and the FDA Food Safety Modernisation Act  (FSMA) designed to make clear specific actions that must be taken to ensure the safety of the food supply among many different points in the global supply chain.


A scientific paper published in European Journal of Public Health reports that those who take probiotics as a preventative measure are less likely to receive antibiotic prescriptions

The systematic review, which was authored by an international group of ten scientists, reviewed studies that administered Lactobacillus or Bifidobacterium to healthy people to determine the impact of probiotics on incidence or duration of common infectious diseases. In all studies that also tracked antibiotic use, the study found that healthy infants and children who consumed probiotics rather than a placebo were at least 29% less likely to receive or consume antibiotics. No studies in adults were included because these studies did not track antibiotic prescriptions.

Link to the pdf paper


NEW IPA EUROPE CRITERIA TO QUALIFY A MICROORGANISM DESIGNATED AS ‘PROBIOTIC’ IN FOODS, BEVERAGES AND DIETARY SUPPLEMENTS

IPA Europe contends that the development of scientifically-based criteria is prerequisite to qualifying a microbial strain as a ‘probiotic’. These criteria are updated as per the latest scientific developments and industry deliberation, to ensure that the probiotic foods industry can consistently create high-quality products that consumers can have confidence in. In developing this voluntary approach, the European probiotic industry shows that it is proactive and responsible when it comes to meaningful self-regulation.

Read the Press Release

Read the Criteria Document


Fermented foods, probiotics and the gut microbiota

Find out what fermented foods and probiotics can do for your health. 

Click here


IPA Europe comments on the EFSA draft scientific and technical guidance

IPA Europe appreciates the opportunity provided by EFSA to comment on the revised draft guidelines for the preparation and presentation of a health claim application. IPA Europe continues to request the possibility of having a dialogue between the applicant and EFSA prior to the submission of a dossier.

22 – 28 avenue d’Auderghem
1040 Brussels
Belgium

    info@ipaeurope.org

    +32 2 549 50 81

    ACCESS MEMBERS ONLY

FOLLOW US

© 2019 ipaeurope.org - All rights reserved